Saccades in presymptomatic and early stages of Huntington disease

Neurology

Volumn 67, Issue 3, 2006, Pages 394-399

  Blekher, T ^a   Johnson, S A ^b   Marshall, J ^a   White, K ^a   Hui, S ^a   Weaver, M ^a   Gray, J ^a   Yee, R ^a   Stout, J C ^b   Beristain, X ^a   Wojcieszek, J ^a   Foroud, T ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b INDIANA UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER;

ADULT; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC ERROR; EYE TRACKING; FEMALE; GENETIC ANALYSIS; HETEROZYGOTE; HUMAN; HUNTINGTON CHOREA; LATENT PERIOD; MAJOR CLINICAL STUDY; MALE; MOTOR DYSFUNCTION; MOTOR PERFORMANCE; POPULATION RISK; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RATING SCALE; RISK ASSESSMENT; SACCADIC EYE MOVEMENT; SENSITIVITY ANALYSIS; STATISTICAL SIGNIFICANCE; SYMPTOMATOLOGY; TASK PERFORMANCE; UNIFIED HUNTINGTON DISEASE RATING SCALE; VELOCITY;

EYE MOVEMENTS; GENETIC PREDISPOSITION TO DISEASE; HUMANS; HUNTINGTON DISEASE; PSYCHOMOTOR PERFORMANCE; SACCADES;

EID: 33747037796     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/01.wnl.0000227890.87398.c1     Document Type: Article

References (27)

1. The Huntington's Disease Collaborative Research Group. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. Cell 1993;72:971-983.
2. Rosas HD, Hevelone ND, Zaleta AK, Greve DN, Salat DH, Fischl B. Regional cortical thinning in preclinical Huntington disease and its relationship to cognition. Neurology 2005;65:745-747.
3. Aylward EH, Sparks BF, Field KM, et al. Onset and rate of striatal atrophy in preclinical Huntington disease. Neurology 2004;63:66-72.
4. Paulsen JS, Zimbelman JL, Hinton SC, et al. fMRI biomarker of early neuronal dysfunction in presymptomatic Huntington's disease. Am J Neuroradiol 2004;25:1715-1721.
5. Reading SA, Dziorny AC, Peroutka LA, et al. Functional brain changes in presymptomatic Huntington's disease. Ann Neurol 2004;55:879-883.
6. Paulsen JS, Zhao H, Stout JS, et al. Clinical markers of early disease in persons near onset of Huntington's disease. Neurology 2001;57:658-662.
7. Gutekunst CA, Li SH, Yi H, et al. Nuclear and neuropil aggregates in Huntington's disease: relationship to neuropathology. J Neurosci 1999;19:2522-2534.
8. Weeks RA, Piccini P, Harding AE, Brooks DJ. Striatal D1 and D2 dopamine receptor loss in asymptomatic mutation carriers of Huntington's disease. Ann Neurol 1996;40:49-54.
9. Leigh RJ, Newman SA, Folstein SE, Lasker AG, Jensen BA. Abnormal ocular motor control in Huntington's disease. Neurology 1983;33:1268-1275.
10. Starr A. A disorder of rapid eye movements in Huntington's chorea. Brain 1967;90:545-564.
11. Lasker AG, Zee DS. Ocular motor abnormalities in Huntington's disease. Vision Res 1997;37:3639-3645.
12. Tian JR, Zee DS, Lasker AG, Folstein SE. Saccades in Huntington's disease: predictive tracking and interaction between release of fixation and initiation of saccades. Neurology 1991;41:875-881.
13. Lasker AG, Zee DS, Hain TC, Folstein SE, Singer HS. Saccades in Huntington's disease: initiation defects and distractibility. Neurology 1987;37:364-370.
14. Rothlind JC, Brandt J, Zee D, Codori AM, Folstein S. Unimpaired verbal memory and oculomotor control in asymptomatic adults with the genetic marker for Huntington's disease. Arch Neurol 1993;50:799-802.
15. Collewijn H, Went LN, Tamminga EP, Vegter-Van der Vlis M. Oculomotor defects in patients with Huntington's disease and their offspring. J Neurol Sci 1988;86:307-320.
16. Kirkwood SC, Siemers E, Hodes ME, Conneally PM, Christian JC, Foroud T. Subtle changes among presymptomatic Huntington's disease gene carriers. J Neurol Neurosurg Psychiatry 2000;69:773-779.
17. Siemers E, Foroud T, Bill DJ, et al. Motor changes in presymptomatic Huntington's disease gene carriers. Arch Neurol 1996;53:487-492.
18. Blekher TM, Yee RD, Kirkwood SC, et al. Oculomotor control in asymptomatic and recently diagnosed individuals with the genetic marker for Huntington's disease. Vision Res 2004;44:2729-2736.
19. The Huntington Study Group. Unified Huntington's Disease Rating Scale: reliability and consistency. Mov Disord 1996;11:136-142.
20. Lahiri DK, Bye S, Nurnberger JIJr., Hodes ME, Crisp M. A nonorganic and non-enzymatic extraction method gives higher yields of genomic DNA from whole-blood samples than do nine other methods tested. J Biochem Biophys Methods 1992;25:193-205.
21. Bond CE, Hodes ME. Direct amplification of the CAG repeat of huntingtin without amplification of CCG. Clin Chem 1996;42:773-774.
22. Bahill AT, Clark MR, Stark L. The main sequence, a tool for studying human eye movements. Math Biosci 1975;24:191-204.
23. Ramchandani VA, O'Connor S, Blekher T, et al. A preliminary study of acute responses to clamped alcohol concentration and family history of alcoholism. Alcohol Clin Exp Res 1999;23:1320-1330.
24. Roy-Byrne P, Radant A, Wingerson D, Cowley DS. Human oculomotor function: reliability and diurnal variation. Biological Psychiatry 1995;38:92-97.
25. Munoz DP, Broughton JR, Goldring JE, Armstrong IT. Age-related performance of human subjects on saccadic eye movement tasks. Exp Brain Res 1998;121:391-400.
26. Leigh RJ, Zee DS. The neurology of eye movements. New York: Oxford Univ Press, 1999.
27. Rebok GW, Bylsma FW, Keyl PM, Brandt J, Folstein SE. Automobile driving in Huntington's disease. Mov Disord 1995;10:778-787.